Drug Pipeline

CAR-T cells Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-29 NCT07612787 A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07612787 A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed… Myeloma Multiple Not Yet Recruiting
Phase 1/2
NCT06429150 Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma Multiple Myeloma Recruiting
Phase 1
NCT03434769 AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma Non-Hodgkin Lymphoma Active, Not Recruiting
Sponsors Running CAR-T cells Trials
Benjamin Tomlinson (1) Shenzhen Geno-Immune Medical Institute (1) Centre Hospitalier Universitaire de Saint Etienne (1)
Disease Areas
Multiple Myeloma (2) Non-Hodgkin Lymphoma (1)
Get alerts when CAR-T cells trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free